Paul Strumph

1.7k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Paul Strumph is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Paul Strumph has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Paul Strumph's work include Diabetes Treatment and Management (17 papers), Pancreatic function and diabetes (16 papers) and Diabetes Management and Research (16 papers). Paul Strumph is often cited by papers focused on Diabetes Treatment and Management (17 papers), Pancreatic function and diabetes (16 papers) and Diabetes Management and Research (16 papers). Paul Strumph collaborates with scholars based in United States, Germany and United Kingdom. Paul Strumph's co-authors include Pablo Lapuerta, Phillip Banks, Anne L. Peters, John B. Buse, Darren K. McGuire, Satish K. Garg, Jake A. Kushner, Thomas Danne, Brian Zambrowicz and Arthur Sands and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Paul Strumph

24 papers receiving 1.3k citations

Hit Papers

Effects of Sotagliflozin Added to Insulin in Patients wit... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
    2017 305 citations Satish K. Garg, Robert R. Henry et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Strumph United States 14 1.2k 811 294 207 82 25 1.3k
Ludwig Merker Germany 10 1.3k 1.1× 719 0.9× 525 1.8× 156 0.8× 193 2.4× 30 1.4k
Aurora Merovci United States 12 995 0.9× 642 0.8× 625 2.1× 72 0.3× 118 1.4× 17 1.2k
H Schmechel Germany 8 796 0.7× 247 0.3× 249 0.8× 181 0.9× 97 1.2× 17 1.1k
M. Nauck Germany 13 458 0.4× 276 0.3× 188 0.6× 45 0.2× 103 1.3× 26 774
Annette Mathisen United States 7 842 0.7× 246 0.3× 829 2.8× 74 0.4× 142 1.7× 9 1.4k
Elke Seewaldt-Becker Germany 7 972 0.8× 588 0.7× 510 1.7× 21 0.1× 160 2.0× 7 1.1k
Fuki Ikeda Japan 15 284 0.2× 216 0.3× 249 0.8× 124 0.6× 39 0.5× 38 753
Katja Fuecker Germany 7 740 0.6× 148 0.2× 322 1.1× 103 0.5× 66 0.8× 9 1.1k
Fabiana Filigheddu Italy 14 432 0.4× 212 0.3× 198 0.7× 73 0.4× 48 0.6× 25 787
Lin Ping United States 8 2.2k 1.9× 739 0.9× 919 3.1× 71 0.3× 420 5.1× 11 2.4k

Countries citing papers authored by Paul Strumph

Since Specialization
Citations

This map shows the geographic impact of Paul Strumph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Strumph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Strumph more than expected).

Fields of papers citing papers by Paul Strumph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Strumph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Strumph. The network helps show where Paul Strumph may publish in the future.

Co-authorship network of co-authors of Paul Strumph

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Strumph. A scholar is included among the top collaborators of Paul Strumph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Strumph. Paul Strumph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bode, Bruce W., Eda Cengiz, R. Paul Wadwa, et al.. (2020). Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study. Diabetes Technology & Therapeutics. 23(1). 59–69. 16 indexed citations
2.
Rodbard, Helena W., Andrea Giaccari, Rosemarie Lajara, et al.. (2020). Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2. Diabetes Obesity and Metabolism. 22(11). 2089–2096. 14 indexed citations
3.
4.
Powell, David R., Brian Zambrowicz, Linda Morrow, et al.. (2019). OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption. Journal of the Endocrine Society. 3(Supplement_1). 2 indexed citations
5.
Powell, David R., Brian Zambrowicz, Linda Morrow, et al.. (2019). Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption. The Journal of Clinical Endocrinology & Metabolism. 105(4). e1235–e1249. 40 indexed citations
6.
Baker, Claire, Suman Wason, Phillip Banks, et al.. (2019). Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial. Diabetes Obesity and Metabolism. 21(11). 2440–2449. 21 indexed citations
7.
Buse, John B., Satish K. Garg, Julio Rosenstock, et al.. (2018). Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 41(9). 1970–1980. 172 indexed citations
8.
Pettus, Jeremy, Stuart A. Weinzimer, Rory J. McCrimmon, et al.. (2018). Sotagliflozin in Combination with Optimized Insulin Therapy Reduced HbA1c Levels with a Decreased Daily Insulin Requirement after 52 Weeks in Adults with T1D. Diabetes. 67(Supplement_1). 3 indexed citations
9.
10.
11.
Garg, Satish K., Robert R. Henry, Phillip Banks, et al.. (2017). Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes. New England Journal of Medicine. 377(24). 2337–2348. 305 indexed citations breakdown →
12.
Sands, Arthur, Brian Zambrowicz, Julio Rosenstock, et al.. (2015). Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes. Diabetes Care. 38(7). 1181–1188. 181 indexed citations
13.
Turner, J. Rick, Desmond Schatz, Kenneth Cusi, & Paul Strumph. (2014). Healthcare Transition from Pediatric to Adult Medical Homes. Endocrine Practice. 20(7). 714–720. 4 indexed citations
14.
Zambrowicz, Brian, Pablo Lapuerta, Paul Strumph, et al.. (2014). LX4211 Therapy Reduces Postprandial Glucose Levels in Patients With Type 2 Diabetes Mellitus and Renal Impairment Despite Low Urinary Glucose Excretion. Clinical Therapeutics. 37(1). 71–82.e12. 34 indexed citations
15.
16.
Strumph, Paul, et al.. (1995). THE EFFECT OF FK506 ON GLYCEMIC RESPONSE AS ASSESSED BY THE HYPERGLYCEMIC CLAMP TECHNIQUE. Transplantation. 60(2). 147–150.
17.
Strumph, Paul, Michael T. Stechison, & Peter A. Lee. (1995). Meningioma In Congenital Adrenal Hyperplasia. Endocrine Practice. 1(3). 161–162. 4 indexed citations
18.
Strumph, Paul, et al.. (1995). THE EFFECT OF FK506 ON GLYCEMIC RESPONSE AS ASSESSED BY THE HYPERGLYCEMIC CLAMP TECHNIQUE. Transplantation. 60(2). 147–150. 18 indexed citations
19.
Strumph, Paul, Charles L. Odoroff, & John M. Amatruda. (1988). The Accuracy of Blood Glucose Testing by Children. Clinical Pediatrics. 27(4). 188–194. 3 indexed citations
20.
Sparks, Charles E., Janet D. Sparks, Mary Bolognino, et al.. (1986). Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism. 35(12). 1128–1136. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ludwig Merker Breakdown of academic impact, for papers by Aurora Merovci Breakdown of academic impact, for papers by H Schmechel Breakdown of academic impact, for papers by M. Nauck Breakdown of academic impact, for papers by Annette Mathisen Breakdown of academic impact, for papers by Elke Seewaldt-Becker Breakdown of academic impact, for papers by Fuki Ikeda Breakdown of academic impact, for papers by Katja Fuecker Breakdown of academic impact, for papers by Fabiana Filigheddu Breakdown of academic impact, for papers by Lin Ping
Rankless by CCL
2026